|
National Stock Number(NSN): 6505-01-259-1553 (6505012591553, 012591553)
| NIIN: |
01-259-1553 |
Item Name: |
GLYBURIDE TABLETS |
INC: |
66764
|
| FSC: |
6505
|
Assignment Date: |
Jul-14-1987 |
CRIT: |
X |
IIG: |
66764 |
| ISC: |
2 |
Date Standardized: |
Oct-11-1988 |
HMIC: |
P |
DODIC: |
|
| NSC: |
0 |
Cancellation Date: |
|
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9290 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
DIABETA TABLETS |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
C |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
NDC00039-0052-03 |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
C |
3 |
9 |
6 |
54 |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
SMS |
Y |
|
Q |
U |
1 |
A |
$5.40 |
BT |
|
C2201X- |
Nov-01-2007 |
H |
| DF |
|
Y |
|
|
|
|
F |
$0.00 |
BT |
|
------- |
Jul-01-2003 |
H |
| DN |
SMS |
Y |
|
Q |
U |
1 |
N |
$5.40 |
BT |
|
9L----- |
Nov-01-2007 |
H |
| DS |
SMS |
Y |
|
Q |
U |
1 |
D |
$5.40 |
BT |
|
------- |
Jun-01-2003 |
H |
| DS |
SMS |
Y |
|
Q |
U |
1 |
I |
$5.40 |
BT |
|
------- |
Jun-01-2003 |
C |
| VA |
G36 |
G |
|
M |
U |
G |
V |
$4.78 |
BT |
|
------- |
Feb-01-1992 |
C |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 30TT |
000 |
|
|
|
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 30TT |
000 |
|
|
|
| DF |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 30TT |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 30TT |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 30 TT |
000 |
|
|
|
| DS |
V |
DISCONTINUED WITHOUT REPLACEMENT |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 30 TT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
5.000 MILLIGRAMS GLYBURIDE ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
CHILD RESISTANT CLOSURE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
30.000 TABLETS |
| CSGS |
ADMINISTRATION |
ORAL |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
GLYBURIDE TABLETS 5MG 30S BT |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| THPE |
THERAPEUTIC EQUIVALENT |
DIABETA BY HOECHST-ROUSSEL PHARM.,INC. |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
1 |
H |
|
|
54 |
54 |
| Description: |
DRUGS/MEDICINES/VITAMINS NOI |
Originating Activity: |
54 |
| Hazardous Material: |
|
National Motor Freight Classification Number: |
058770 |
| Less Than One Truckload: |
W |
NMFC Sub-Item: |
Z |
| Uniform Freight Classification Number: |
33400 |
Rail Variance Code: |
|
| Less Than One Carload: |
|
Water Commodity Code: |
532 |
| Type of Cargo Code: |
Z |
Special Handling Code: |
9 |
| Air Commodity Special Handling Code: |
MZ |
Air Dimension Code: |
A |
|